What global initiative focuses on the standardization of drug quality across countries?

The International Conference on Harmonisation (ICH) is the correct choice because it is specifically designed to promote uniform standards for the quality, safety, and efficacy of pharmaceuticals across different regions, particularly among the major drug regulatory authorities in Europe, Japan, and the United States. The initiative works towards harmonizing the regulatory requirements for the development and approval of drugs, which supports the globalization of drug quality standards. This harmonization helps reduce the reliance on different standards in various countries, thus improving the overall quality of medicines and facilitating global trade.

The World Health Organization (WHO) does contribute to public health and sets international health standards, but its focus is broader and not specifically centered on drug quality standardization like the ICH. The Food and Drug Administration (FDA) primarily regulates drugs and consumer products within the United States, without direct authority to standardize drug quality on a global scale. The European Medicines Agency (EMA) operates similarly within the European Union, providing centralized drug approval but does not encompass a global perspective on drug quality standardization in the way that the ICH does.